Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.
AUTOR(ES)
Sanchez, J
RESUMO
We have constructed an overexpression system in which the gene encoding the B subunit of cholera toxin (CTB) was placed under the control of the strong tacP promoter in a wide host range plasmid. Recombinant nontoxigenic classical and E1 Tor Vibrio cholerae strains of different serotypes harboring this plasmid excreted 10- to 100-fold higher amounts of CTB than any other wild-type or recombinant strain tested and may therefore be useful killed oral vaccine strains. The manipulations to place the CTB gene under tacP also included, by design, the introduction of single enzyme restriction sites for gene fusions to the CTB amino terminus. Cloning into these sites allows construction of CTB-derived hybrid proteins carrying various putative vaccine peptide antigens.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=286494Documentos Relacionados
- Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.
- Characterization of recombinant tetanus toxin derivatives suitable for vaccine development.
- Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.
- Effectiveness of Liposomes Possessing Surface-Linked Recombinant B Subunit of Cholera Toxin as an Oral Antigen Delivery System
- Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
